| 214.63 Delayed Data As of Feb 27 |  -3.26 / -1.50%Today’s Change | 115.31 Today|||52-Week Range 219.11 | +15.11% Year-to-Date |
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.
| 3 ETFs Surging at Start of 2015 - ETF News And Commentary Feb 27 / Zacks.com | Biotech Juggernaut Keeps Rolling Feb 24 / TheStreet.com |
| The Best Biotech ETF Isn't Always The Biggest Feb 25 / Benzinga | Biotech Juggernaut Keeps Rolling Feb 24 / TheStreet.com |
| 1 month | +6.80% | 3 years | +41.30% | |
| 3 months | +21.01% | 5 years | +31.50% | |
| 1 year | +29.79% | Since inception | +18.15% |
| Previous close | $217.89 |
| Open day’s range | 212.90 – 217.63 |
| Net asset value (NAV) | 217.90 (02/26/2015) |
| Daily volume | 916,125 |
| Average volume (3 months) | 681,151 |
| XBI | Category | |
|---|---|---|
| Performance 5-yr return | +31.50% | +22.29% |
| Expense Gross exp ratio | 0.35% | 0.47% |
| Risk 5 year sharpe ratio | 1.17 | 1.47 |
| Net assets | $1.8B | $1.6B |
| Average market cap | $2.2B | $35.3B |
| Average P/E | -- | 26.2 |
| Dividend / Share | -- | 0.21% |
| XLV Health Care Select Sector SPDR® Fund |
| VHT Vanguard Health Care Index Fund ETF Shar... |
| RYH Guggenheim S&P 500® Equal Weight Health... |
| Healthcare | 100.00% |
| Business service | 0.00% |
| Consumer goods | 0.00% |
| Consumer service | 0.00% |
| Energy | 0.00% |
| FMI Foundation Medicine Inc | 2.23% |
| HALO Halozyme Therapeutics Inc | 1.97% |
| NBIX Neurocrine Biosciences Inc | 1.68% |
| OPK OPKO Health Inc | 1.63% |
| ICPT Intercept Pharmaceuticals Inc | 1.61% |
| -- | 1.61% |
| RARE Ultragenyx Pharmaceutical Inc | 1.54% |
| NVAX Novavax Inc | 1.49% |
| EXEL Exelixis Inc | 1.47% |
| ALKS Alkermes Plc | 1.46% |
